Cell-free DNA for aneuploidy screening in embryos? Join the discussion

Progenesis is dedicated to innovation in reproductive health. As such, our expert scientists are constantly working to improve our products and practices through research and development.

We recently collaborated on a study investigating the use of cell-free DNA for aneuploidy screening in embryos. The manuscript detailing this study, “Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos,” was published in the August 2018 edition of Fertility and Sterility, the official journal of the American Society of Reproductive Medicine.

This week we learned that our study has been selected for Fertility and Sterility’s upcoming Journal Club Global. The event will be live-streamed on Thursday November 15th at 10AM PST (1PM EST).

REGISTER for the online event to join in the discussion of this exciting topic!

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *